CFO Antonio Zamora Galland stated that the financing serves the company's broader strategy to bolster its working capital management and maintain a stable financial foundation for future business growth. The deal marks a significant step in the company's efforts to manage its liabilities amid its ongoing expansion in the Latin American pharmaceutical and personal care markets.

Jorge Rohana de la Vega, Corporate Director at Banamex, emphasized that the partnership aligns with the bank's commitment to supporting the growth of domestic companies across various sectors. Genomma Lab, which trades on the Mexican Stock Exchange under the ticker LABB, continues to operate its unique model of consumer-oriented marketing and a flexible, low-cost supply chain.